Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06287463
Status:
RECRUITING
Last Update Posted:
2024-06-24
First Post:
2024-02-23
Brief Title:
Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase MAPK Pathway
Sponsor:
Deciphera Pharmaceuticals LLC
Organization:
Deciphera Pharmaceuticals LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Solid Tumor |
| RAF Mutation |
| RAS Mutation |
| NF1 Mutation |
| Non-Small Cell Lung Cancer |
| Pancreatic Ductal Adenocarcinoma |
| Melanoma |
| BRAF Gene Mutation |
| CRAF Gene Mutation |
Keywords:
| Name | View |
|---|---|
| Advanced malignancies | View |